Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.57 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.50 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.50 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.50 |
| ▸ | HNF4A | P41235 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | TACR1 | P25103 | 2/20 | 0.47 |
| ▸ | FABP3 | P05413 | 1/20 | 0.44 |
| ▸ | FABP4 | P15090 | 1/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5163372 | 0.94 | CES1 (0.50) | BCAT2CES1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL29035974 | 0.86 | BCAT2 (0.55) | BCAT2MEN1KMT2ASMN1; SMN2CHRNB2 | |
| SCHEMBL28774592 | 0.83 | BCAT2 (0.61) | BCAT2MEN1KMT2ASMN1; SMN2CHRNB2 | |
| Trifluoroacetic Acid SCHEMBL16720000 | 0.82 | HNF4A (0.56) | BCAT2MEN1KMT2ASMN1; SMN2CHRNB2 | |
| SCHEMBL13543201 | 0.82 | BCAT2 (0.59) | BCAT2MEN1KMT2ASMN1; SMN2CHRNB2 | |
| Trifluoroacetic Acid SCHEMBL1786045 | 0.79 | BCAT2 (0.79) | BCAT2MEN1KMT2ASMN1; SMN2CHRNB2 | |
| Trifluoroacetic Acid SCHEMBL31255509 | 0.79 | BCAT2 (0.79) | BCAT2MEN1KMT2ASMN1; SMN2CHRNB2 | |
| SCHEMBL16567335 | 0.79 | AKR1C3 (0.47) | CES1HTTHDAC6TACR1ALDH1A1 | |
| SCHEMBL18043680 | 0.79 | PTGDR2 (0.47) | CES1SMN1; SMN2HDAC6TSHRFABP4 | |
| SCHEMBL28361773 | 0.79 | SLC6A2 (0.59) | MEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250243310-A1 | ANION EXCHANGE BRANCHED CO-POLYMER WITH POLY(ARYL) AND A BRANCHED COMPOUND AND QUINUCLIDINIUM SIDE CHAINS AND SYNTHESIS THEREOF | USA FORTESCUE IP INC (US) | 2025-07-31 | — | — | US | disclosed |
| US-12283729-B2 | Anion exchange branched co-polymer with poly(aryl) and a branched compound and quinuclidinium side chains and synthesis thereof | USA FORTESCUE IP INC (US) | 2025-04-22 | — | — | US | disclosed |
| US-20250062377-A1 | ANION EXCHANGE BRANCHED CO-POLYMER WITH POLY(ARYL) AND A BRANCHED COMPOUND AND QUINUCLIDINIUM SIDE CHAINS AND SYNTHESIS THEREOF | USA FORTESCUE IP INC (US) | 2025-02-20 | — | — | US | disclosed |
| WO-2024216181-A1 | ANION EXCHANGE BRANCHED CO-POLYMER WITH POLY(ARYL) AND A BRANCHED COMPOUND AND QUINUCLIDINIUM SIDE CHAINS AND SYNTHESIS THEREOF | USA Fortescue IP, Inc. (US) | 2024-10-17 | — | — | WO | disclosed |
| CN-110862299-B | Method for synthesizing 9-hydroxy-9 trifluoromethyl fluorene compound | 浙江工业大学 | 2022-10-11 | — | — | CN | disclosed |
| CN-107324970-B | Crosslinking agent and fluorine-containing aromatic compound | 霓佳斯株式会社 | 2021-06-29 | — | — | CN | disclosed |
| CN-106574074-B | Crosslinking agent and fluorine-containing aromatic compound | 霓佳斯株式会社 | 2020-06-23 | — | — | CN | disclosed |
| CN-110862299-A | Method for synthesizing 9-hydroxy-9 trifluoromethyl fluorene compound | 浙江工业大学 | 2020-03-06 | — | — | CN | disclosed |
| EP-3187527-B1 | CROSSLINKING AGENT AND FLUORINE-CONTAINING AROMATIC COMPOUND | NICHIAS CORP (JP) | 2019-10-30 | — | — | EP | disclosed |
| EP-2386547-B1 | Multicyclic amino acid derivatives and methods of their use | LEXICON PHARMACEUTICALS INC (US) | 2018-06-20 | — | — | EP | disclosed |
| WO-2009009561-A1 | METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION AND RELATED DISEASES AND DISORDERS | LEXICON PHARMACEUTICALS, INC. (US) | 2009-01-15 | — | — | WO | disclosed |
| US-20090005382-A1 | METHODS OF USING AND COMPOSITIONS COMPRISING TRYPTOPHAN HYDROXYLASE INHIBITORS | TERSERA THERAPEUTICS LLC | 2009-01-01 | — | — | US | disclosed |
| US-20090005381-A1 | METHODS OF TREATING SEROTONIN-MEDIATED DISEASES AND DISORDERS | LEXICON PHARMACEUTICALS, INC. | 2009-01-01 | — | — | US | disclosed |
| WO-2009002964-A1 | METHODS OF TREATING SEROTONIN-MEDIATED DISEASES AND DISORDERS | LEXICON PHARMACEUTICALS, INC. (US) | 2008-12-31 | — | — | WO | disclosed |
| WO-2009002970-A1 | COMPOSITIONS COMPRISING TRYPTOPHAN HYDROXYLASE INHIBITORS | LEXICON PHARMACEUTICALS, INC. (US) | 2008-12-31 | — | — | WO | disclosed |
| EP-1984344-A2 | MULTICYCLIC AMINO ACID DERIVATIVES AND METHODS OF THEIR USE | Lexicon Pharmaceuticals, Inc. (US) | 2008-10-29 | — | — | EP | disclosed |
| WO-2008009815-A2 | METHOD FOR PREPARING AROMATIC SULFONATES | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2008-01-24 | — | — | WO | disclosed |
| WO-2008009816-A2 | AROMATIC SULFINATES AND SULFONYL HALIDES, AND THE PREPARATION THEREOF | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2008-01-24 | — | — | WO | disclosed |
| US-20070191370-A1 | Multicyclic amino acid derivatives and methods of their use | TERSERA THERAPEUTICS LLC | 2007-08-16 | — | — | US | disclosed |
| WO-2007089335-A2 | MULTICYCLIC AMINO ACID DERIVATIVES AND METHODS OF THEIR USE | LEXICON PHARMACEUTICAL INC. (US) | 2007-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191370-A1 | Multicyclic amino acid derivatives and methods of their use | AADAT, HNMT, TPH1 | BCAT2 16/4885CES1 1312/4885MEN1 1261/4885 |
| US-20090005381-A1 | METHODS OF TREATING SEROTONIN-MEDIATED DISEASES AND DISORDERS | TPH1, TPH2, HNMT | BCAT2 677/4885CES1 558/4885MEN1 1824/4885 |
| US-20090005382-A1 | METHODS OF USING AND COMPOSITIONS COMPRISING TRYPTOPHAN HYDROXYLASE INHIBITORS | TPH1, TPH2, MAOB | BCAT2 405/4885CES1 286/4885MEN1 3750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.